John A. Fair's most recent trade in Dare Bioscience Inc was a trade of 290,000 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on March 12, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Dare Bioscience Inc | John A. Fair | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2024 | 290,000 | 290,000 | - | - | Employee Stock Option (right to buy) | |
Dare Bioscience Inc | John A. Fair | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2023 | 290,000 | 290,000 | - | - | Stock Option (right to buy) | |
Dare Bioscience Inc | John A. Fair | Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2022 | 185,000 | 185,000 | - | - | Stock Option (right to buy) | |
Dare Bioscience Inc | John A. Fair | Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2021 | 168,000 | 168,000 | - | - | Stock Option (right to buy) |